SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?


To: TI2, TechInvestorToo who wrote (3741)11/28/2000 9:07:14 PM
From: RJMC  Respond to of 5665
 
Your guess is as good as mine. I think it would be dependent on just how effective the drug is in the various Phase II trials. As for the conference. Who knows, maybe as early as the AACR conference in April for the Chicago trials?

Bob M.